Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AACR 2020
Pharma
Roche's Tecentriq on top of Yescarta doesn't help clear cancer
By studying Yescarta plus Roche’s Tecentriq, Gilead aimed to find out if adding a PD-L1 drug to CAR-T therapy could help clear lymphoma. It didn't.
Carly Helfand
Apr 27, 2020 2:31am
Novartis' capmatinib tackles lung cancer in the brain: study
Apr 27, 2020 12:01am
Adding Roche's Tecentriq to Xtandi doesn't extend lives
Apr 27, 2020 12:01am
Roche's Tecentriq, on top of targeted drugs, stalls melanoma
Apr 27, 2020 12:01am
Merck pads case for convenient Keytruda dosing with new data
Apr 27, 2020 12:01am
